1. Home
  2. PROK vs ILPT Comparison

PROK vs ILPT Comparison

Compare PROK & ILPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • ILPT
  • Stock Information
  • Founded
  • PROK 2015
  • ILPT 2017
  • Country
  • PROK United States
  • ILPT United States
  • Employees
  • PROK N/A
  • ILPT N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • ILPT Real Estate Investment Trusts
  • Sector
  • PROK Health Care
  • ILPT Real Estate
  • Exchange
  • PROK Nasdaq
  • ILPT Nasdaq
  • Market Cap
  • PROK 334.8M
  • ILPT 400.0M
  • IPO Year
  • PROK N/A
  • ILPT 2018
  • Fundamental
  • Price
  • PROK $3.11
  • ILPT $5.50
  • Analyst Decision
  • PROK Buy
  • ILPT
  • Analyst Count
  • PROK 5
  • ILPT 0
  • Target Price
  • PROK $6.25
  • ILPT N/A
  • AVG Volume (30 Days)
  • PROK 2.5M
  • ILPT 359.5K
  • Earning Date
  • PROK 11-11-2025
  • ILPT 10-28-2025
  • Dividend Yield
  • PROK N/A
  • ILPT 3.60%
  • EPS Growth
  • PROK N/A
  • ILPT N/A
  • EPS
  • PROK N/A
  • ILPT N/A
  • Revenue
  • PROK $527,000.00
  • ILPT $443,468,000.00
  • Revenue This Year
  • PROK $338.06
  • ILPT $3.44
  • Revenue Next Year
  • PROK N/A
  • ILPT $1.78
  • P/E Ratio
  • PROK N/A
  • ILPT N/A
  • Revenue Growth
  • PROK N/A
  • ILPT 0.36
  • 52 Week Low
  • PROK $0.46
  • ILPT $2.45
  • 52 Week High
  • PROK $7.13
  • ILPT $6.57
  • Technical
  • Relative Strength Index (RSI)
  • PROK 54.93
  • ILPT 40.20
  • Support Level
  • PROK $2.34
  • ILPT $5.53
  • Resistance Level
  • PROK $3.02
  • ILPT $5.75
  • Average True Range (ATR)
  • PROK 0.17
  • ILPT 0.20
  • MACD
  • PROK 0.03
  • ILPT -0.08
  • Stochastic Oscillator
  • PROK 65.59
  • ILPT 11.82

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

About ILPT Industrial Logistics Properties Trust of Beneficial Interest

Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.

Share on Social Networks: